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Abstract
Background: To investigate the effect of primary phacoemulsification on intraocular pressure (IOP) in patients with acute
primary angle-closure (PAC) and coexisting cataract.
Methodology: Sixteen eyes of 14 patients with acute PAC received phacoemulsification and intraocular lens implantation as
initial management for medically uncontrolled IOP in a retrospective chart review. The effects on IOP, vision, anterior
chamber depth (ACD), and number of antiglaucoma medications were evaluated.
Principal Findings: The postoperative IOP was reduced in 16 eyes (100%). The mean 6 standard deviation preoperative IOP
was 48.81616.83 mm Hg, which decreased postoperatively to 16.46610.67 mm Hg at 1 day, 9.4363.03 mm Hg at 1 week,
9.4962.14 mm Hg at 2 weeks, 10.7863.56 mm Hg at 1 month, and 10.7062.80 mm Hg at 3 months (p,0.001). The mean
number of antiglaucoma medications decreased from 3.5661.14 to 0.1360.34 (p,0.001). The average preoperative ACD
was 2.0860.35 mm, which increased to 3.5960.33 mm after surgery (p,0.001). Visual acuity (converted into logarithm of
the minimum angle of resolution [logMAR]) improved from 1.1460.71 to 0.7360.53 (p=0.001).
Conclusions: Primary phacoemulsification plus intraocular lens implantation lowered IOP, reduced the use of antiglaucoma
medications, and improved vision in patients with acute PAC. This is a safe and effective method of IOP control and can be
considered a first treatment option in managing patients with acute PAC and coexisting cataract.
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Introduction
Acute primary angle closure (PAC) is an ophthalmic emergency
that demands prompt intervention and effective treatment.
Traditional treatment of acute PAC involves lowering intraocular
pressure (IOP) with systemic and topical medications [1,2]. Once
the acute attack has been resolved, peripheral iridectomy or
iridotomy (PI), either surgically or by laser, is usually performed to
relieve pupillary block and to create a new route for aqueous
humor egress. However, successful PI does not always achieve
satisfactory IOP control [3–6].
Anterior displacement of the iris-lens diaphragm causing a shallow
anterior chamber remains the major predisposing factor in acute
primaryangle-closureglaucoma(PACG)orPAC[7].Eyeswithangle
closure tend to have a shallow anterior chamber and a thick,
anteriorly positioned lens compared with normal eyes [7–12]. It was
reported that cataract surgery widened the iridocorneal angle and
attenuated the anterior positioning of the ciliaryprocesses in eyes with
PAC [13]. Recently, increased evidence has shown that primary lens
extraction not only reverses the acute attack of PACG but also
achieves long-term IOP control [14–19]. The purpose of the current
study was to evaluate the effects of primary phacoemulsification and
intraocular lens (IOL) implantation on IOP, vision, anterior chamber
depth (ACD), and use of antiglaucoma medication in eyes with acute
PAC and coexisting cataract.
Materials and Methods
Objective
To investigate the effect of primary phacoemulsification and
IOL implantation on IOP, vision, ACD, and use of antiglaucoma
medication in eyes with acute PAC and coexisting cataract.
Participants
From January 2006 to December 2009, 16 eyes of 14 patients
with acute PAC and coexisting cataract received phacoemulsifica-
tion and IOL implantation as initial treatment for medically
uncontrolled IOP.Thesepatientsrepresented partofthe acutePAC
cases of Chang Gung Memorial Hospital during the period under
review, who visited the authors’ clinic on an emergent consultation
basis. The clinical diagnostic criteria for acute PAC were as follows:
presentation with typical symptoms (ocular pain, blurry or halo
vision, nausea or vomiting), acute increase in IOP to above
22 mm Hg, presence of ciliary flush, microcystic corneal edema,
mid-dilated pupil, glaukomflecken, and occludable drainage angle.
Patients with secondary glaucoma, history of uveitis, ocular trauma,
previous ocular surgeries, or other ocular diseases were excluded.
The enrolled patients presented visually significant intumescent
cataracts which were considered to impede the normal aqueous
outflow pathway and thus subject to acute IOP rise.
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Initial medical treatment. After the diagnosis of acute PAC
was made, these patients received first-line medical treatment for
IOP control, including a combination of topical beta-blockers,
brimonidine, carbonic anhydrase inhibitors (CAIs), and additional
systemic hyperosmotic agents (intravenous mannitol, 1 mg/kg)
and CAIs (acetazolamide, 250 mg four times daily).
Preoperative evaluation. The enrolled patients underwent a
complete ocular examination before surgery, including best-
corrected visual acuity (BCVA), IOP, keratometry, slit-lamp
examination, and fundus examination. Contact A-scan biomi-
croscopy was performed to measure the ACD and axial length and
to calculate IOL power. Visual acuity was measured with the
Landolt C chart, and the value was converted into that in the
logarithm of the minimum angle of resolution (logMAR).
Surgical procedure. After providing written informed
consent, the enrolled patients underwent phacoemulsification,
aspiration, and IOL implantation. All surgical procedures were
performed by one surgeon (WWS). Except for one operation in
which general anesthesia was used, all surgeries were performed
under topical anesthesia. The surgical procedure in brief was as
follows: after anesthesia and sterile procedure, a standard
phacoemulsification was performed through a 2.65-mm clear
corneal incision. An additional puncture was made at the limbus
for chopper insertion. After injection of viscoelastic materials for
anterior chamber maintenance, a continuous curvilinear
capsulorrhexis (CCC) and hydrodissection were performed. The
lens was phacoemulsified, and the cortical remnants were removed
by irrigation and aspiration. A foldable hydrophobic acrylic IOL
(SA60AT, Alcon, Fort Worth, TX) was implanted in the bag.
After complete removal of viscoelastic materials, the clear corneal
incision was hydrosealed or sutured with one stitch of 10/0
Nylone, depending on the final wound condition. Postoperative
medication included a combination of tobramycin and
dexamethasone suspension four times a day. The dosage was
rapidly reduced within 1 month depending on the degree of
postoperative inflammation.
Postoperative evaluation. Patients were followed up the
morning after surgery, as well as 1 week, 2 weeks, 1 month, and 3
months postoperatively. A complete ocular examination was
performed each time, including visual acuity (VA), IOP, slit-
lamp examination, and fundus examination. Contact A-scan
biomicroscopy was performed at the fourth visit to evaluate ACD
and axial length changes.
Ethics
The enrolled patients all provided written informed consent.
The study has been approved by the institutional review board of
Chang Gung Memorial Hospital.
Statistical analysis
Continuous variables were expressed as mean 6 standard
deviation (SD), and categorical data were represented by number
(n) and percentage (%). Variables were compared using a paired t
test. IOP at different time points was analyzed by repeated
measure one-way ANOVA. All statistical assessments were 2-
sided, and a p level of 0.05 was considered statistically significant.
Results
The mean 6 SD age of the patients was 72.6363.72 years. Five
patients (35.7%) were male and nine (64.3%) were female. Most of
the patients underwent surgery within 2 weeks after the acute PAC
attack, with an average interval of 12.9469.12 days. The mean
IOP at the time of acute PAC attack was 48.81616.83 mm Hg,
which decreased significantly after surgery as follows: 1 day,
16.46610.67 mm Hg, 1 week, 9.4363.03 mm Hg, 2 weeks,
9.4962.14 mm Hg, 1 month, 10.7863.56 mm Hg, and 3
months, 10.7062.80 mm Hg. A repeated measure one-way
ANOVA with a Greenhouse-Geisser correction determined that
IOP differed statistically significantly between time points
(p,0.001) (Figure 1, Table 1). The mean number of antiglaucoma
medications decreased from 3.5661.41 preoperatively to
0.1360.34 postoperatively (p,0.001). The preoperative BCVA
(converted into logMAR) was 1.1460.71, and the postoperative
value was 0.7360.53 (p=0.001). The mean ACD increased from
2.0860.35 mm preoperatively to 3.5960.33 mm postoperatively
(p,0.001). The preoperative spherical equivalent was
22.0762.85 D, and the postoperative value was 20.2561.16 D
(p=0.068). The average implanted IOL power was 22.6362.69 D
(Table 1). There were no significant postoperative complications.
Transient IOP spikes were observed in two cases (12.5%).
Discussion
Iridolenticular apposition with subsequent pupillary block is a
well-established etiology in PACG [7]. The iridolenticular
apposition can worsen with age as the enlarging lens pushes the
iris-lens diaphragm forward, narrowing the anterior chamber
angle and predisposing the patient to develop angle-closure
glaucoma (ACG). In the past 2 decades, an increasing number
of cataract extractions had been associated with a corresponding
decrease in the incidence of ACG [20–22]. This provides
anecdotal evidence of a relationship between cataract and PACG.
The ‘‘lens factor’’ in the pathogenesis of ACG can also be
confirmed in other ways. Markowitz and Morin defined the lens
thickness–to–axial length ratio (LT/AL) as a unifying index for
biometric assessment of patients with ACG [23]. A greater LT/AL
was strongly correlated with a shorter time before peripheral
iridectomy was required [24]. Patients with a greater LT/AL were
also more predisposed to acute angle-closure attack [12]. Using
ultrasound biomicroscopy, Kurimoto et al. reported significant
increases in ACD and trabecular-iris angle after phacoemulsifica-
tion and IOL implantation, especially in eyes with a narrower
anterior chamber [25]. Yang and Hung reported significant ACD
increase and angle widening after extracapsular cataract extrac-
tion (ECCE) in patients with chronic PACG, using Scheimpflug
image processing [26]. These findings provide evidence for lens
participation in the pathogenesis of ACG and indicate beneficial
effects of lens removal in PACG. Recently, increasing evidence has
supported the effectiveness of primary cataract extraction in long-
term IOP control, not only in patients with chronic PACG but also
in those with acute PACG [14–19,27]. Our results showed
significantly reduced IOP, decreased use of antiglaucoma
medications, and increased ACD after phacoemulsification and
IOL implantation in patients with acute PAC. These results were
consistent with previous reports and suggest that primary cataract
extraction can be considered an alternative therapeutic option for
medically uncontrolled acute PAC.
Phacoemulsification in eyes with acute PAC has unique
difficulties. The cornea is usually hazy, precluding a clear view.
The shallow anterior chamber provides limited room for
maneuvering the nucleus, and the ultrasonic power applied must
be close to the corneal endothelium. However, with the reduction
of the nucleus size after several sculptings, more room is created
and the anterior chamber deepens gradually, making the
subsequent procedures easier. The small pupil and the atonic iris
that are commonly found in post-acute-PAC eyes raise another
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which needs to be addressed very carefully. In managing eyes with
small pupils, we gently stretch the iris with Sinski hooks bimanually to
enlarge the pupilsize before CCC andphacoemulsification, or use iris
retractors as needed. None of the cases in our series demonstrated
significant corneal decompensation during postoperative follow-up,
and this surgically related complication is acceptable.
The eyes in our series underwent primary phacoemulsification
without previous iridotomy. Iridectomy, performed either by laser
or surgically, has been a classic treatment for PACG. Iridotomy
relieves pupillary block by creating a new route for aqueous humor
to egress from the posterior to the anterior chamber. However, a
patent iridotomy does not always achieve satisfactory IOP control,
and its effect may also diminish with time [3–6]. Jacobi et al.
compared the effect on IOP of primary phacoemulsification and of
conventional surgical iridectomy in patients with acute PACG.
Their report showed better IOP control in the phacoemulsification
group. Surgical iridectomy was effective in reducing IOP initially
but was associated with multiple surgical reinterventions [16]. In a
randomized trial, Lam et al. reported that early phacoemulsifica-
tion (1 month after the abortion of the acute PAC) was more
effective in preventing IOP increase than laser peripheral
iridotomy in patients with acute PAC [6]. These results confirmed
that lens extraction is better than iridectomy for uncontrolled
PACG. In our series, most patients received primary phacoemul-
sification within 2 weeks after the acute PAC attack, suggesting
that early phacoemulsification alone can achieve good IOP control
in patients with medically uncontrolled acute PAC, with limited
complications. However, besides the optimal timing of surgery, we
suggest that the treatment plane be individualized depending on
the patient’s age, glaucoma stage, general health condition, and
other risk factors.
Figure 1. Intraocular pressure changes after phacoemulsification+intraocular lens implantation.
doi:10.1371/journal.pone.0020056.g001
Table 1. Comparison of patients’ pre- and post-operative characteristics.
Pre-OP Post-OP p value
IOP (mmHg) 48.81616.83 16.46610.67 (1 day) p,0.001
9.4363.03 (1 week)
9.4962.14 (2 weeks)
10.7863.56 (1 month)
10.7062.80 (3 months)
ACD (mm) 2.0860.35 3.5960.33 p,0.001
Anti-glaucoma medication 3.5661.14 0.1360.34 p,0.001
VA (logMAR) 1.1460.71 0.7360.53 p=0.001
Spherical equivalent (diopter) 22.0762.85 20.2561.16 p=0.068
IOL power (diopter) 22.6362.69D
doi:10.1371/journal.pone.0020056.t001
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Primary phacoemulsification plus IOL implantation is a safe
and effective method of IOP control for patients with acute PAC.
This procedure alone can be considered a first treatment of choice
for patients with medically uncontrolled acute PAC and coexisting
cataract.
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